GIM-407

N/A

Report date: 2024/08/06 20:00:05

NMEFirst In Class

Base Information

Drug NameGIM-407

Drug Alias NameGIM-407

ClassificationSmall molecules

Mechanisms of ActionRegulatory T-lymphocytes stimulants

TargetsUpdating

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesGeorgiamune Inc

China Registration ClassN/A

Active CompaniesGeorgiamune Inc

Inactive CompaniesN/A

Active IndicationsAutoimmune Diseases

Inactive IndicationsN/A

ATC CodeN/A